GlassScriptPhysician profile
Samantha D Winerman
NPI 1265877849
$10,221.41
in general payments reported to CMS, 2019-2025
24 companies · $1,421 in 2025
The $1,421 reported for 2025 was more than what 77% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,329 · 2020: $850 · 2021: $1,539 · 2022: $1,021 · 2023: $2,236 · 2024: $825 · 2025: $1,421.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,310 · Travel and Lodging: $2,171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,310.47 |
| Travel and Lodging | $2,171.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $3,167.35 | 2019-2023 | Stravix, Grafix |
| Stryker Corporation | $3,113.33 | 2019-2024 | Augment Injectable, Axsos, Gamma |
| Kerecis Limited | $1,025.14 | 2020-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen |
| Treace Medical Concepts, INC. | $887.45 | 2021-2025 | |
| Wright Medical Technology, INC. | $583.95 | 2019-2020 | |
| Oak Med, INC. | $409.07 | 2025 | |
| Arthrex, INC. | $288.20 | 2025 | |
| Organogenesis INC. | $172.93 | 2021-2025 | Puraply, Via Matrix |
| Abbott Laboratories | $69.88 | 2021-2023 | Proclaim |
| Dynasplint Systems INC. | $62.55 | 2019 | |
| Horizon Therapeutics Plc | $56.23 | 2019 | |
| Mimedx Group, INC. | $47.17 | 2024-2025 | |
| Djo, LLC | $45.13 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $44.52 | 2019 | |
| Musculoskeletal Transplant Foundation INC. | $42.72 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Osiris Therapeutics INC. | $40.57 | 2019 | |
| Melinta Therapeutics, LLC | $30.55 | 2019 | |
| Integra Lifesciences Corporation | $27.38 | 2020 | |
| Orthofix Medical, INC. | $21.02 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.90 | 2023 | Jublia |
| Medtronic, INC. | $20.10 | 2022 | |
| Paragon 28, INC. | $17.25 | 2023 | |
| Polarityte, INC. | $16.09 | 2019 | |
| Medline Industries LP | $11.93 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samantha Winerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.